173 related articles for article (PubMed ID: 23613723)
1. Prognostic significance of EBV latent membrane protein 1 expression in lymphomas: evidence from 15 studies.
Mao Y; Lu MP; Lin H; Zhang DW; Liu Y; Li QD; Lv ZG; Xu JR; Chen RJ; Zhu J
PLoS One; 2013; 8(4):e60313. PubMed ID: 23613723
[TBL] [Abstract][Full Text] [Related]
2. Effect of latent membrane protein 1 expression on overall survival in Epstein-Barr virus-associated cancers: a literature-based meta-analysis.
Chen YP; Zhang WN; Chen L; Tang LL; Mao YP; Li WF; Liu X; Zhou GQ; Sun Y; Kang TB; Zeng MS; Liu N; Ma J
Oncotarget; 2015 Oct; 6(30):29311-23. PubMed ID: 26336130
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of latent membrane protein 1 expression in non-Hodgkin lymphoma: A meta-analysis.
Li XM; Xiao WH; Zhao HX
Medicine (Baltimore); 2017 Apr; 96(14):e6512. PubMed ID: 28383415
[TBL] [Abstract][Full Text] [Related]
4. Determination of frequency of epstein-barr virus in non- Hodgkin lymphomas Using EBV latent membrane protein 1 (EBV-LMP1) immunohistochemical staining.
Ishtiaq S; Hassan U; Mushtaq S; Akhtar N
Asian Pac J Cancer Prev; 2013; 14(6):3963-7. PubMed ID: 23886215
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus encoded latent membrane protein 1 (LMP1) and TNF receptor associated factors (TRAF): colocalisation of LMP1 and TRAF1 in primary EBV infection and in EBV associated Hodgkin lymphoma.
Siegler G; Kremmer E; Gonnella R; Niedobitek G
Mol Pathol; 2003 Jun; 56(3):156-61. PubMed ID: 12782762
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr Virus-Encoded Latent Membrane Protein 1 and B-Cell Growth Transformation Induce Lipogenesis through Fatty Acid Synthase.
Hulse M; Johnson SM; Boyle S; Caruso LB; Tempera I
J Virol; 2021 Jan; 95(4):. PubMed ID: 33208446
[TBL] [Abstract][Full Text] [Related]
7. LMP1-deficient Epstein-Barr virus mutant requires T cells for lymphomagenesis.
Ma SD; Xu X; Plowshay J; Ranheim EA; Burlingham WJ; Jensen JL; Asimakopoulos F; Tang W; Gulley ML; Cesarman E; Gumperz JE; Kenney SC
J Clin Invest; 2015 Jan; 125(1):304-15. PubMed ID: 25485679
[TBL] [Abstract][Full Text] [Related]
8. EBV LMP2A affects LMP1-mediated NF-kappaB signaling and survival of lymphoma cells by regulating TRAF2 expression.
Guasparri I; Bubman D; Cesarman E
Blood; 2008 Apr; 111(7):3813-20. PubMed ID: 18230756
[TBL] [Abstract][Full Text] [Related]
9. [C-terminal 30 bp-deletion mutation of latent membrane protein 1 gene of Epstein-barr virus in non-hodgkin's lymphoma].
Liu JR; Lin Q; Wu XY
Ai Zheng; 2005 Feb; 24(2):145-8. PubMed ID: 15694022
[TBL] [Abstract][Full Text] [Related]
10. Latent membrane protein 1 (LMP1) expression in Hodgkin lymphoma and its correlation with clinical and histologic parameters.
Hashmi AA; Hussain ZF; Hashmi KA; Zafar MI; Edhi MM; Faridi N; Khan M
World J Surg Oncol; 2017 Apr; 15(1):89. PubMed ID: 28427406
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of EBV-LMP1 and VEGF-A expressions in non-Hodgkin's lymphomas.
Paydas S; Ergin M; Erdogan S; Seydaoglu G
Leuk Res; 2008 Sep; 32(9):1424-30. PubMed ID: 18282597
[TBL] [Abstract][Full Text] [Related]
12. Assessment of the prognostic impact of the Epstein-Barr virus-encoded latent membrane protein-1 expression in Hodgkin's disease.
Glavina-Durdov M; Jakic-Razumovic J; Capkun V; Murray P
Br J Cancer; 2001 May; 84(9):1227-34. PubMed ID: 11336475
[TBL] [Abstract][Full Text] [Related]
13. Frequent expression of the tumor necrosis factor receptor-associated factor 1 in latent membrane protein 1-positive posttransplant lymphoproliferative disease and HIV-associated lymphomas.
Murray PG; Swinnen LJ; Flavell JR; Ragni MV; Baumforth KR; Toomey SM; Filipovich AH; Lowe D; Schnell CS; Johl J; Gulley M; Young LS; Ambinder RF
Hum Pathol; 2001 Sep; 32(9):963-9. PubMed ID: 11567226
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23.
Wang F; Gregory C; Sample C; Rowe M; Liebowitz D; Murray R; Rickinson A; Kieff E
J Virol; 1990 May; 64(5):2309-18. PubMed ID: 2157887
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus latent membrane protein-1 up-regulates cytokines and correlates with older age and poorer prognosis in Hodgkin lymphoma.
Chang KC; Chen PC; Chang Y; Wu YH; Chen YP; Lai CH; Medeiros LJ; Su IJ; Wang HW
Histopathology; 2017 Feb; 70(3):442-455. PubMed ID: 27632954
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus and a cellular signaling pathway in lymphomas from immunosuppressed patients.
Liebowitz D
N Engl J Med; 1998 May; 338(20):1413-21. PubMed ID: 9580648
[TBL] [Abstract][Full Text] [Related]
17. PD-L1 is upregulated by EBV-driven LMP1 through NF-κB pathway and correlates with poor prognosis in natural killer/T-cell lymphoma.
Bi XW; Wang H; Zhang WW; Wang JH; Liu WJ; Xia ZJ; Huang HQ; Jiang WQ; Zhang YJ; Wang L
J Hematol Oncol; 2016 Oct; 9(1):109. PubMed ID: 27737703
[TBL] [Abstract][Full Text] [Related]
18. Follicular dendritic cells display microvesicle-associated LMP1 in reactive germinal centers of EBV+ classic Hodgkin lymphoma.
Uccini S; Al-Jadiry MF; Pepe G; Pasquini A; Alsaadawi AR; Al-Hadad SA; Di Napoli A; Tripodo C; Ruco L
Virchows Arch; 2019 Aug; 475(2):175-180. PubMed ID: 31203443
[TBL] [Abstract][Full Text] [Related]
19. [Expression of ZEBRA protein of Epstein-Barr virus in Hungarian patients with Hodgkin lymphoma: latent or lytic cycle?].
Beck Z; Illés A; Keresztes K; Bessenyei B; Szöllosi Z; Kis A; Oláh E
Orv Hetil; 2006 Aug; 147(33):1539-44. PubMed ID: 17037676
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus latent membrane protein-1 upregulates autophagy and promotes viability in Hodgkin lymphoma: Implications for targeted therapy.
Lin HC; Chang Y; Chen RY; Hung LY; Chen PC; Chen YP; Medeiros LJ; Chiang PM; Chang KC
Cancer Sci; 2021 Apr; 112(4):1589-1602. PubMed ID: 33525055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
